Study number 780511
Dates
Mar 29 2026-Jun 11 2026
Location
Madison, Wisconsin
Age
18-70
Gender
Males and Females
Smoker
No
Compensation
13,088
Group
C1
This is a research study for an investigational drug that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with type 2 diabetes and other conditions.
Fortrea Madison, WI is currently recruiting Healthy Adults, ages 18-70
Body Mass Index
Smoking Criteria
Screening procedures
Cohort 1:
Check-in: Mar 29, May 4
Check-out: Apr 6, May 12
Outpatient visits: Apr 13, 20, May 19, 26, Jun 9